370 related articles for article (PubMed ID: 9165041)
1. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
Virkamäki A; Daniels MC; Hämäläinen S; Utriainen T; McClain D; Yki-Järvinen H
Endocrinology; 1997 Jun; 138(6):2501-7. PubMed ID: 9165041
[TBL] [Abstract][Full Text] [Related]
2. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
[TBL] [Abstract][Full Text] [Related]
3. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo.
Yki-Järvinen H; Virkamäki A; Daniels MC; McClain D; Gottschalk WK
Metabolism; 1998 Apr; 47(4):449-55. PubMed ID: 9550544
[TBL] [Abstract][Full Text] [Related]
4. Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L
J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789
[TBL] [Abstract][Full Text] [Related]
5. UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues.
Yki-Järvinen H; Vogt C; Iozzo P; Pipek R; Daniels MC; Virkamäki A; Mäkimattila S; Mandarino L; DeFronzo RA; McClain D; Gottschalk WK
Diabetologia; 1997 Jan; 40(1):76-81. PubMed ID: 9028721
[TBL] [Abstract][Full Text] [Related]
6. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.
Rossetti L; Hawkins M; Chen W; Gindi J; Barzilai N
J Clin Invest; 1995 Jul; 96(1):132-40. PubMed ID: 7615783
[TBL] [Abstract][Full Text] [Related]
7. Short-term glucosamine infusion does not affect insulin sensitivity in humans.
Pouwels MJ; Jacobs JR; Span PN; Lutterman JA; Smits P; Tack CJ
J Clin Endocrinol Metab; 2001 May; 86(5):2099-103. PubMed ID: 11344213
[TBL] [Abstract][Full Text] [Related]
8. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
[TBL] [Abstract][Full Text] [Related]
9. Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart.
Virkamäki A; Yki-Järvinen H
Diabetes; 1999 May; 48(5):1101-7. PubMed ID: 10331416
[TBL] [Abstract][Full Text] [Related]
10. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.
Yki-Järvinen H; Daniels MC; Virkamäki A; Mäkimattila S; DeFronzo RA; McClain D
Diabetes; 1996 Mar; 45(3):302-7. PubMed ID: 8593934
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.
Cooksey RC; Hebert LF; Zhu JH; Wofford P; Garvey WT; McClain DA
Endocrinology; 1999 Mar; 140(3):1151-7. PubMed ID: 10067838
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase.
Crook ED; Zhou J; Daniels M; Neidigh JL; McClain DA
Diabetes; 1995 Mar; 44(3):314-20. PubMed ID: 7883119
[TBL] [Abstract][Full Text] [Related]
13. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle.
Patti ME; Virkamäki A; Landaker EJ; Kahn CR; Yki-Järvinen H
Diabetes; 1999 Aug; 48(8):1562-71. PubMed ID: 10426374
[TBL] [Abstract][Full Text] [Related]
14. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.
Baron AD; Zhu JS; Zhu JH; Weldon H; Maianu L; Garvey WT
J Clin Invest; 1995 Dec; 96(6):2792-801. PubMed ID: 8675649
[TBL] [Abstract][Full Text] [Related]
15. Glucose-induced insulin resistance of phosphatidylinositol 3'-OH kinase and AKT/PKB is mediated by the hexosamine biosynthesis pathway.
Singh LP; Gennerette D; Simmons S; Crook ED
J Diabetes Complications; 2001; 15(2):88-96. PubMed ID: 11274905
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.
Veerababu G; Tang J; Hoffman RT; Daniels MC; Hebert LF; Crook ED; Cooksey RC; McClain DA
Diabetes; 2000 Dec; 49(12):2070-8. PubMed ID: 11118009
[TBL] [Abstract][Full Text] [Related]
18. Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases in vivo insulin sensitivity in conscious adult rats.
Koopmans SJ; Leighton B; DeFronzo RA
Diabetologia; 1998 Jul; 41(7):813-20. PubMed ID: 9686923
[TBL] [Abstract][Full Text] [Related]
19. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid.
McClain DA; Hazel M; Parker G; Cooksey RC
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E973-9. PubMed ID: 15613679
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts enhances glucose-mediated glycogen accumulation via suppression of glycogen phosphorylase activity.
Crook ED; Crenshaw G; Veerababu G; Singh LP
Endocrinology; 2000 Jun; 141(6):1962-70. PubMed ID: 10830278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
